美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
53746-515-90	53746-515	HUMAN PRESCRIPTION DRUG	Spironolactone	Spironolactone	TABLET	ORAL	20100802	N/A	ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	100 mg/1	90 TABLET in 1 BOTTLE (53746-515-90)
54348-340-90	54348-340	HUMAN PRESCRIPTION DRUG	Spironolactone	SPIRONOLACTONE	TABLET	ORAL	20190709	N/A	ANDA	ANDA091426	PharmPak, Inc.	SPIRONOLACTONE	50 mg/1	1 BOTTLE in 1 BOX (54348-340-90) / 90 TABLET in 1 BOTTLE
53746-511-60	53746-511	HUMAN PRESCRIPTION DRUG	Spironolactone	Spironolactone	TABLET	ORAL	20100802	N/A	ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	25 mg/1	60 TABLET in 1 BOTTLE (53746-511-60)
53746-511-90	53746-511	HUMAN PRESCRIPTION DRUG	Spironolactone	Spironolactone	TABLET	ORAL	20100802	N/A	ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	25 mg/1	90 TABLET in 1 BOTTLE (53746-511-90)
71610-102-60	71610-102	HUMAN PRESCRIPTION DRUG	Spironolactone	Spironolactone	TABLET	ORAL	20180726	N/A	ANDA	ANDA091426	Aphena Pharma Solutions - Tennessee, LLC	SPIRONOLACTONE	25 mg/1	90 TABLET in 1 BOTTLE (71610-102-60)
53746-514-01	53746-514	HUMAN PRESCRIPTION DRUG	Spironolactone	Spironolactone	TABLET	ORAL	20100802	N/A	ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	50 mg/1	100 TABLET in 1 BOTTLE (53746-514-01)
53746-514-05	53746-514	HUMAN PRESCRIPTION DRUG	Spironolactone	Spironolactone	TABLET	ORAL	20100802	N/A	ANDA	ANDA091426	Amneal Pharmaceuticals of New York LLC	SPIRONOLACTONE	50 mg/1	500 TABLET in 1 BOTTLE (53746-514-05)